|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
07666 METIS TECHBIO-P
Nominal 
() | 2025/12 - Final RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | (121,593) | (239,210) | (192,428) |
| Net Cash from / (used in) Investing Activities | 35,092 | 78,925 | (404,892) |
| Net Cash from / (used in) Financing Activities | 369,479 | 143,311 | 799,937 |
| Increase / (Decrease) in Cash & Cash Equivalents | 282,978 | (16,974) | 202,617 |
| Cash & Cash Equivalents at beginning of period | 557,641 | 561,470 | 364,472 |
| Effect of Foreign Exchange Rate Changes | (12,356) | 13,145 | (5,619) |
| Others | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | 828,263 | 557,641 | 561,470 |
| Remarks: | Real time quote last updated: 08/05/2026 17:16 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -391,836 |
| %Change | -21.507% |
| EPS / (LPS) | RMB -- |
| NBV Per Share (¥) | RMB -- |